DIRECT. Results of the study on effectiveness of candesartan (angiotensin II receptor antaginist) in prevention of diabetes retinopathy progression
https://doi.org/10.14341/2072-0351-5364
References
1. Sjolie A.K., Porta M., Parving HH., Bilous R., Klein R. The DIabetic REtinopathy Candersantan Trials (DIRECT) Programme: baseline characteristics. JRAAS 2005; 6(1): 25-32.
2. Sjolie A.K. Prospects for angiotensin receptor blockers in diabetic retinopathy. Diabetes Research and Clinical Practice 2007; 76(1): S31-S39.
3. Early Treatment of Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic colour fundus photographs - an extension of the Modified Airlie House classification. ETDRS Report number 10. Ophthalmology 1991; 98:786-806.
4. www DIRECT-results.org
Review
For citations:
DIRECT. Results of the study on effectiveness of candesartan (angiotensin II receptor antaginist) in prevention of diabetes retinopathy progression. Diabetes mellitus. 2008;11(3):63-65. (In Russ.) https://doi.org/10.14341/2072-0351-5364
Views:
925
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
